You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: September 16, 2024

CLINICAL TRIALS PROFILE FOR CARISBAMATE

✉ Email this page to a colleague

« Back to Dashboard

Clinical Trials for Carisbamate

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00210522 ↗	An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy	Completed	SK Life Science	Phase 2	The purpose of this study is to evaluate the effectiveness and safety of the novel compound RWJ-333369 in reducing the frequency of seizures in patients with epilepsy.
NCT00210522 ↗	An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy	Completed	SK Life Science, Inc.	Phase 2	The purpose of this study is to evaluate the effectiveness and safety of the novel compound RWJ-333369 in reducing the frequency of seizures in patients with epilepsy.
NCT00210652 ↗	An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy	Completed	SK Life Science	Phase 2	The purpose of this study is to evaluate the safety and preliminary effectiveness of the novel compound RWJ-333369 in patients with partial onset seizures who are currently being treated with 1 or 2 concomitant antiepileptic drugs.
NCT00210652 ↗	An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy	Completed	SK Life Science, Inc.	Phase 2	The purpose of this study is to evaluate the safety and preliminary effectiveness of the novel compound RWJ-333369 in patients with partial onset seizures who are currently being treated with 1 or 2 concomitant antiepileptic drugs.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Summary

Clinical Trial Conditions for Carisbamate

Condition Name

Chart
Table

Condition Name
Intervention	Trials
Epilepsy	4
Epilepsies, Partial	3
Epilepsy, Complex Partial	3
Lennox Gastaut Syndrome	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH
Intervention	Trials
Epilepsy	6
Epilepsies, Partial	5
Seizures	5
Epilepsy, Complex Partial	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Carisbamate

Trials by Country

Map
Table

Trials by Country
Location	Trials
United States	24
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State
Location	Trials
Utah	3
Pennsylvania	2
Oregon	2
New York	2
New Hampshire	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Carisbamate

Clinical Trial Phase

Chart
Table

Clinical Trial Phase
Clinical Trial Phase	Trials
Phase 3	5
Phase 2	6
Phase 1/Phase 2	1
[disabled in preview]	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status
Clinical Trial Phase	Trials
Completed	11
Recruiting	2
Terminated	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Carisbamate

Sponsor Name

Chart
Table

Sponsor Name
Sponsor	Trials
SK Life Science, Inc.	14
SK Life Science	10
Baylor College of Medicine	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type
Sponsor	Trials
Industry	25
Other	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.